Safety and efficacy of simultaneous use of Mifepristone and Misoprostol in second trimester termination of pregnancy

Sayali Shripad Jahagirdar, Pushpa Shankarrao Junghare


Background: Combination of Mifepristone and Misoprostol has been successfully used for termination of pregnancy up to 63 days however no specific protocol is available for use in termination of pregnancy in second trimester. There are various regimens regarding optimal dose of Mifepristone and Misoprostol to be used in second trimester termination of pregnancy. Most of the regimens have a 24 to 48 hr. interval in administering the two drugs.

Methods: This is a non-randomized prospective single arm interventional study approved by ethical committee of our institution and carried out over a period of 2 years from January 2013 to December 2014.This trial was also registered under Clinical Trial Registry Of India CTRI/2013/03/003488.152 healthy women who wanted to undergo second trimester termination of pregnancy were included in the study after applying inclusion and exclusion criteria. All women received T Mifepristone 200mg orally along with T Misoprostol 400mcg placed vaginally in the posterior fornix. T Misoprostol 200 mcg was placed vaginally every 4hrs till good uterine contractions were established. The end point of the study was complete abortion with expulsion of placenta. The induction abortion interval was noted. Women were observed for complications and women needing additional intervention to complete the abortion process were also noted.

Results: The mean induction abortion interval was 783.17 minutes (13 hrs.) in our study which was comparable to similar study by Chai J et al in which induction-to-abortion interval was 10 hours 96% of women aborted in 24 hrs. and 100% in 32 hrs. in our study. 81% had no complications and 17% had minor complications which were managed by medicines alone.

Conclusions: Simultaneous use of Mifepristone and misoprostol is both safe and effective in termination of pregnancy in second trimester.


Misoprostol, Mifepristone, Second trimester termination of pregnancy

Full Text:



Safe abortion: Technical and policy guidance for health systems (2nd ed.) Geneva: World Health Organization, 2012.

Ngoc NT, Shochet T, Raghavan S, et al. Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial Obstet Gynecol. 2011;118(3):601-8.

Chai J, Tang OS, Hong QQ, et al. A randomized trial to compare two dosing intervals of misoprostol following Mifepristone administration in second trimester medical abortion. Human Reproduction. 2009;24(2),320-324.

Ashok P, Templeton A, Wagaarachchi P, Flett G. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception. 2044;69(1):51-58.

Gemzell-Danielsson K1, Lalitkumar S.Second trimester medical abortion with Mifepristone-Misoprostol and Misoprostol alone: a review of methods and management. Reprod Health Matters. 2008;16(31):162-72.

Goyal, V. Uterine rupture in second-trimester misoprostol-induced abortion after cesarean delivery: A systematic review. Obstetrics and Gynecology. 2009;113(5),1117-1123.

Mentula M, Heikinheimo O. Risk factors of surgical evacuation following second-trimester medical termination of pregnancy. Contraception. 2012;86(2):141-6

Sharma D, Singhal SR, Poonam, Paul A, Kunika. Comparison of Mifepristone combination with misoprostol and misoprostol alone in the management of intrauterine death: condensation - misoprostol and Mifepristone combination is more effective than misoprostol alone in the management of intrauterine death. Taiwan J Obstet Gynecol. 2011;50(3):322-5.